|
Since South Korea seems to be the model here for dealing with the coronavirus pandemic, here are the treatment Guidelines from South Korea:
According to the Korea Biomedical Review, the South Korean COVID-19 Central Clinical Task Force guidelines are as follows:
1. If patients are young, healthy, and have mild symptoms without underlying conditions, doctors can observe them without antiviral treatment;
2. If more than 10 days have passed since the onset of the illness and the symptoms are mild, physicians do not have to start an antiviral medication;
3. However, if patients are old or have underlying conditions with serious symptoms, physicians should consider an antiviral treatment. If they decide to use the antiviral therapy, they should start the administration as soon as possible:
chloroquine 500mg orally per day.
[the guidelines mention other antivirals as further lines of defense, including anti-HIV drugs.]
4. As chloroquine is not available in Korea, doctors could consider hydroxychloroquine 400mg orally per day (Hydroxychloroquine is an analog of chloroquine used against malaria, autoimmune disorders, etc. It is widely available as well)
5. The treatment is suitable for 7 - 10 days, which can be shortened or extended depending on clinical progress.
|